Related Experiment Video
Updated: Jul 31, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment
Dylan R Kirn1,2, Joshua D Grill3,4,5, Paul Aisen6
1Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. dkirn@mgh.harvard.edu.
Centralized collection of prescreening data in multi-site clinical trials is feasible. This approach can identify and address selection bias, improving trial design and enrollment for diverse populations.
Area of Science:
- Clinical Trials
- Health Services Research
- Gerontology
Background:
- Recruiting demographically representative samples for multi-site trials is challenging.
- Disparities in race and ethnicity enrollment and randomization are documented.
- Pre-consent recruitment disparities, particularly during prescreening, are under-investigated.
Purpose of the Study:
- To develop and assess an infrastructure for centrally collecting prescreening data in multi-site clinical trials.
- To identify potential participant loss prior to screening and address selection bias.
- To inform recruitment strategies and improve trial design and enrollment timelines.
Main Methods:
- Developed a centralized data collection infrastructure within the National Institute on Aging (NIA) Alzheimer's Clinical Trials Consortium (ACTC).
- Collected prescreening variables (age, sex, race, ethnicity, education, occupation, zip code, recruitment source, eligibility status, ineligibility reason) during a vanguard phase of the AHEAD 3-45 study.
- Collected data from seven study sites prior to full study-wide implementation.
Main Results:
- Centralized capture of prescreening data was feasible across all participating vanguard sites.
- Prescreening data was collected on 1029 participants, with significant variation in numbers per site.
- Learnings from the vanguard phase informed design, informatics, and procedural changes for study-wide launch.
Conclusions:
- Centralized capture of prescreening data in multi-site clinical trials is feasible and valuable.
- This data can identify and quantify the impact of recruitment activities before consent.
- Potential benefits include addressing selection bias, optimizing resource use, improving trial design, and accelerating enrollment.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...